Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1990 2
1991 2
1992 3
1995 1
2004 3
2005 5
2006 1
2007 1
2008 2
2009 4
2010 6
2011 6
2012 8
2013 8
2014 6
2015 2
2016 2
2018 1
2019 4
2020 4
2021 1
2022 10
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean s fukuhara[Author] (2,183 results)?
Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial.
Krop IE, Masuda N, Mukohara T, Takahashi S, Nakayama T, Inoue K, Iwata H, Yamamoto Y, Alvarez RH, Toyama T, Takahashi M, Osaki A, Saji S, Sagara Y, O'Shaughnessy J, Ohwada S, Koyama K, Inoue T, Li L, Patel P, Mostillo J, Tanaka Y, Sternberg DW, Sellami D, Yonemori K. Krop IE, et al. Among authors: mukohara t. J Clin Oncol. 2023 Dec 20;41(36):5550-5560. doi: 10.1200/JCO.23.00882. Epub 2023 Oct 6. J Clin Oncol. 2023. PMID: 37801674 Free PMC article. Clinical Trial.
Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.
Imamura Y, Mukohara T, Shimono Y, Funakoshi Y, Chayahara N, Toyoda M, Kiyota N, Takao S, Kono S, Nakatsura T, Minami H. Imamura Y, et al. Among authors: mukohara t. Oncol Rep. 2015 Apr;33(4):1837-43. doi: 10.3892/or.2015.3767. Epub 2015 Jan 29. Oncol Rep. 2015. PMID: 25634491
Finally, we compared staining for Ki-67 and caspases in the 2D- and 3D-primary-cultured cells originating from a patient-derived xenograft (PDX), fresh PDX tumor, and the patient's original tumor; 2D-cultured cells showed greater proportions of Ki-67-positive and caspase-3 …
Finally, we compared staining for Ki-67 and caspases in the 2D- and 3D-primary-cultured cells originating from a patient-derived xenograft ( …
Graves' Disease after Adrenalectomy for Cushing's Syndrome.
Hiromatsu Y, Eguchi H, Nakamura Y, Mukohara K. Hiromatsu Y, et al. Among authors: mukohara k. Intern Med. 2021 Jan 1;60(1):99-103. doi: 10.2169/internalmedicine.4469-20. Epub 2020 Sep 5. Intern Med. 2021. PMID: 32893226 Free PMC article.
A 44-year-old woman presented with a 3-month history of back pain, gait disturbance, and insomnia. She had moon face and central obesity but no goiter. Cushing's syndrome due to left adrenal adenoma was diagnosed. She also had low triiodothyronine syndrome and central hypo …
A 44-year-old woman presented with a 3-month history of back pain, gait disturbance, and insomnia. She had moon face and central obesity but …
Mitigation of paclitaxel-induced peripheral neuropathy in breast cancer patients using limb-cooling apparatus: a study protocol for a randomized controlled trial.
Funasaka C, Hanai A, Zenda S, Mori K, Fukui M, Hirano N, Shinohara R, Fuse N, Wakabayashi M, Itagaki M, Tomioka Y, Nishina M, Arai Y, Kogawa T, Ozaki Y, Nishimura M, Kobayashi T, Hara F, Takano T, Mukohara T. Funasaka C, et al. Among authors: mukohara t. Front Oncol. 2023 Jul 7;13:1216813. doi: 10.3389/fonc.2023.1216813. eCollection 2023. Front Oncol. 2023. PMID: 37483483 Free PMC article.
Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer.
Mukohara T. Mukohara T. Cancer Sci. 2011 Jan;102(1):1-8. doi: 10.1111/j.1349-7006.2010.01711.x. Epub 2010 Sep 6. Cancer Sci. 2011. PMID: 20825420 Free article. Review.
However, despite this clinical usefulness, unmet needs for better prediction of trastuzumab's response and overcoming primary and acquired resistance remain. ...
However, despite this clinical usefulness, unmet needs for better prediction of trastuzumab's response and overcoming primary and acq …
Public perceptions of physician-pharmaceutical industry relationships and trust in physicians.
Saito S, Mukohara K, Shimomura K, Murotani K. Saito S, et al. Among authors: mukohara k. PLoS One. 2023 Nov 28;18(11):e0294854. doi: 10.1371/journal.pone.0294854. eCollection 2023. PLoS One. 2023. PMID: 38015917 Free PMC article.
This study aimed to clarify the Japanese public perceptions of physicians' relationships with PRs, examine the association between these perceptions and their trust in physicians, and compare the public's and physicians' awareness, acceptance, and perceptions of the influe …
This study aimed to clarify the Japanese public perceptions of physicians' relationships with PRs, examine the association between these per …
Pharmacokinetic study of the oral fluorouracil antitumor agent S-1 in patients with impaired renal function.
Goto K, Fujiwara Y, Isobe T, Chayahara N, Kiyota N, Mukohara T, Tsubata Y, Hotta T, Tamura K, Yamamoto N, Minami H. Goto K, et al. Among authors: mukohara t. Cancer Sci. 2019 Jun;110(6):1987-1994. doi: 10.1111/cas.14025. Epub 2019 May 11. Cancer Sci. 2019. PMID: 30989775 Free PMC article.
The daily S-1 dose was adjusted based on the patient's eGFR and body surface area. ...In conclusion, dose adjustment of S-1 in patients with impaired renal function using eGFR is appropriate and safe....
The daily S-1 dose was adjusted based on the patient's eGFR and body surface area. ...In conclusion, dose adjustment of S …
74 results